Major UK retailers are introducing premium CBD serums, microdose topicals and pharmacy‑grade patches in 2026. This article explains the latest 2023–2026 clinical evidence, post‑Brexit safety expectations, product innovation and sustainability credentials UK shoppers should look for.

This 2026 UK guide explains how CBD fits into post‑workout recovery for athletes and gym‑goers while navigating WADA/UKAD rules. Learn the difference between topical balms and oral oils, why batch testing and COAs matter, and practical steps to reduce anti‑doping risk.

The FSA’s September 2025 Novel Food consultation is paving the way for regulated CBD edibles in Great Britain — especially microdosed gummies. Brands should prepare for mandatory safety warnings, exacting labelling and COA transparency, while consumers will benefit from clearer potency labelling and new trust tools as edible launches scale.